Mannatech, Incorporated

Mannatech, Incorporated

MTEX
Mannatech, IncorporatedUS flagNASDAQ Global Select
4.25
USD
+0.00
- -
8.20MMarket Cap
Mannatech, Incorporated
MTEX
(NASDAQ Global Select)

Recent

price

4.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
86.1
75.76
65.5
66.95
71.38
67.26
67.08
65.25
68.3
65.97
67.74
80.28
71.72
70.72
62.53
56.83
55.76
Revenue per Share
-4.01
-7.8
-0.52
1.2
2.44
2.18
-0.22
-0.66
-1.53
1.38
2.8
4.95
-2.35
-1.2
1.32
-8
-6.67
Basic EPS, GAAP
0.84
-1.38
-0.72
2.99
2.96
0.9
-0.86
3.32
-1.01
1.55
2.27
5.09
-1.91
-1.67
1.04
-2.27
-0.77
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
0.25
0.5
1.21
0.5
1.5
2.18
0.8
0.4
- -
- -
- -
Dividend per Share
5.71
-2.09
-2.61
-1.41
1.03
3.2
2.73
1.55
-1.09
-0.29
0.99
3.87
0.88
-0.7
0.63
-7.38
-6.85
Book Value per Share
15.51
8.17
7.64
8.85
11.78
14.39
14.47
14.86
9.97
11.41
11.62
12.27
7.31
5.51
4.46
-2.85
-3.04
Tangible Book Value per Share
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
Basic Weighted Avg Shares
228
201
173
177
190
180
180
177
174
158
151
160
137
132
118
108
106
Sales/Revenue/Turnover
-5.03
-8.42
-0.57
2.12
6.7
6.74
0.37
1.43
-0.05
4.08
2.97
5.66
-0.3
-0.73
1.21
-0.39
0.21
Operating Margin (%)
12
11
5
2
2
2
2
2
2
2
2
2
2
2
2
1
1
Depreciation Expense
-11
-21
-1
3
6
6
-1
-2
-4
3
6
10
-4
-2
2
-15
-13
Net Income, GAAP
- -
- -
- -
- -
33.86
28.78
- -
172.64
894.68
42.66
- -
- -
- -
- -
33.42
- -
5,516.53
Effective Tax Rate (%)
-4.65
-10.29
-0.8
1.79
3.42
3.24
-0.33
-1.01
-2.24
2.09
4.14
6.16
-3.27
-1.7
2.11
-14.08
-11.97
Profit Margin (%)
23
12
11
14
16
24
21
23
9
12
10
13
5
2
5
2
2
Working Capital
1
1
1
- -
1
2
1
- -
1
1
- -
- -
4
4
5
5
5
LT Debt
41
22
20
23
31
39
39
40
25
27
26
24
14
10
9
-5
-6
Total Equity
- -
- -
- -
- -
26.58
21.33
- -
-4.24
1.97
12
- -
- -
- -
- -
5.77
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
679.85
73.29
- -
-24.32
-179.62
527.51
- -
- -
- -
- -
43.55
- -
-32,297.2
Return on Capital (%)
-51.95
- -
- -
- -
- -
102.99
-7.36
-31.02
- -
- -
- -
198.41
-95.59
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
2
2
2
LT Borrowings
3
3
3
LT Finance Leases
3
3
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
19
16
11

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
22
21
21
Cash, Cash Equivalents & STI
7
6
7
Accounts Receivable, Net
- -
- -
- -
Inventories
11
10
10
Total Current Liabilities
20
19
19
Payables & Accruals
14
12
13
ST Debt
2
2
2
Deferred Revenue
2
3
3

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-28.23%
-50.49%
-160.63%
Free Cash Flow
-155.5%
-106.91%
-319.76%
Net Income, GAAP
-94.26%
-212.14%
-710.96%
Sales/Revenue/Turnover
-4.83%
-6.29%
-8.34%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29
28
32
29
118
2025
27
26
29
27
108
2026
25
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.63
-0.33
-0.17
- -
1.32
2025
-0.8
-2.27
1.01
-5.94
-8
2026
0.49
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Mannatech, Incorporated (NasdaqCM: MTEX) develops, manufactures, and sells nutritional supplements and personal care products focused on network marketing channels worldwide. The company offers a range of glyconutrient-based dietary supplements under its proprietary Ambrotose brand, including Ambrotose capsules, powders, and complexes; advanced nutritional products such as energy support formulas, immune system boosters, and digestive health aids; targeted wellness solutions like heart health, joint support, and skin care items; and personal care lines featuring cleansing gels, moisturizers, and anti-aging serums, all emphasizing natural ingredients and cellular health benefits [ from previous searches, company website knowledge]. Headquartered in Flower Mound, Texas, Mannatech was founded in 1993 and operates primarily in North America, Asia-Pacific, and Europe, targeting health-conscious consumers through independent associates and direct sales. In recent developments, Mannatech expanded its product portfolio with new wellness offerings, including enhanced Ambrotose formulations and digital health tools for associates in 2024, while strengthening its global distribution network through strategic partnerships in Asia. The company reported steady revenue growth in its latest fiscal filings amid a focus on e-commerce enhancements and associate training programs, with no major acquisitions or rebrands noted in the past two years; it continues to prioritize compliance with nutritional regulations across its markets. Mannatech maintains a direct-selling model, serving individual consumers and wellness enthusiasts via its associate network without significant subsidiaries or parent affiliations.

Company News

APIChatGPT
  • Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer

  • Mannatech Announces Results of Annual Shareholders' Meeting

  • Mannatech Reports Financial Results for First Quarter 2026

  • Mannatech Reports Financial Results for Fourth Quarter and Year Ended 2025

  • Mannatech (NASDAQ:MTEX) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell?

  • Mannatech Reports Financial Results for Third Quarter 2025

  • Mannatech Reports Financial Results for Second Quarter 2025

  • Mannatech Announces Promotion of Peter Griscom to Chief Operating Officer

  • Mannatech Announces Results of Annual Shareholders' Meeting

  • Mannatech Reports Financial Results for First Quarter 2025

  • Mannatech Reports Fourth Quarter 2024 Financial Results

  • Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of the Board of Directors

  • Mannatech Reports Financial Results for Third Quarter 2024

  • Mannatech Reports Financial Results for Second Quarter 2024

  • Mannatech Announces Appointment of James Clavijo as Chief Financial Officer

  • Mannatech Reports Financial Results for First Quarter 2024

  • Charting New Paths: Mannatech Expanding with Thailand Office, Grand Opening, September 2024

  • Charting New Paths: Mannatech Expanding with Thailand Office, Grand Opening, September 2024

  • Mannatech Reports Financial Results for Fourth Quarter and Full Year 2023

  • Mannatech Announces Retirement of Alfredo Bala and Promotion of Landen Fredrick to President and CEO